Evidence map›Paper›PMID 28864055›Full record

ReviewChest2017

Tracheobronchopathy From Inhaled Corticosteroids.

Bryan C Husta, Suhail Raoof, Serpil Erzurum, Atul C Mehta

Erratum issuedAbstract readReview
In one paragraph

Review in Chest, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Association between Inhaled Corticosteroids and Expiratory Central Airway Collapse in Smokers.American journal of respiratory and critical care medicine · 2021
    Article
  5. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Bryan C HustaLenox Hill Hospital, Hofstra Northwell School of Medicine, New York, NY.
Suhail RaoofLenox Hill Hospital, Hofstra Northwell School of Medicine, New York, NY.
Serpil ErzurumLerner Research Institute, Cleveland Clinic, Cleveland, OH.
Atul C MehtaRespiratory Institute, Cleveland Clinic, Cleveland, OH. Electronic address: mehtaa1@ccf.org.

Funding

Targeting pathological hyaluronan matricesP01HL103453 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI REIZES, OFER · 2011 to 2020
$26.8M
Tissue Processing and Cell Culture COreP01HL081064 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI ARONICA, MARK A · 2006 to 2019
$17.8M
Airway redox biochemistry as a deteriminant of asthma phenotype during adolescen*U10HL109250 · NHLBI · UNIVERSITY OF VIRGINIA · PI ERZURUM, SERPIL C., GASTON, BENJAMIN · 2011 to 2016
$4.2M
NHLBI NIH HHS P01 HL081064NHLBI NIH HHS P01 HL103453NHLBI NIH HHS U10 HL109250
6 · The paper itself

Abstract

Inhaled corticosteroids (ICSs) have become the mainstay of asthma control. They are also recommended as an add-on therapy to long-acting beta agonists and anticholinergics in moderate to severe COPD with recurrent exacerbations. Ultimately this clinical practice has led to the widespread use of ICSs, which are supported by a more favorable side effect profile than that of systemic steroids.

Indexed as

Administration, InhalationAdrenal Cortex HormonesAsthmaBronchial DiseasesHumansTracheal DiseasesAdrenal Cortex Hormonesexcessive dynamic airway collapseinhaled corticosteroidstracheobronchomalaciatracheomalacia

Identifiers

PMID28864055
PMCPMC6026226

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.